Team:Caltech/Biosafety
From 2008.igem.org
(Difference between revisions)
Line 10: | Line 10: | ||
*'''Short Term:''' There are no safety concerns beyond that of typical ''E. coli'' lab strains. Considering that 260 mM H<sub>2</sub>O<sub>2</sub> is applied directly to the skin to disinfect cuts and scrapes, the 800 uM H<sub>2</sub>O<sub>2</sub> produced by the engineered strain should not be a health concern to anyone working in the lab. | *'''Short Term:''' There are no safety concerns beyond that of typical ''E. coli'' lab strains. Considering that 260 mM H<sub>2</sub>O<sub>2</sub> is applied directly to the skin to disinfect cuts and scrapes, the 800 uM H<sub>2</sub>O<sub>2</sub> produced by the engineered strain should not be a health concern to anyone working in the lab. | ||
*'''Long Term:''' Production of hydrogen peroxide is not a normal occurance in the large instestine, and its effects would need to be investigated before the engineered strain could be used to fight infection. Some concerns of hydrogen peroxide production in the intestine would be if: | *'''Long Term:''' Production of hydrogen peroxide is not a normal occurance in the large instestine, and its effects would need to be investigated before the engineered strain could be used to fight infection. Some concerns of hydrogen peroxide production in the intestine would be if: | ||
- | **it irritates the bowel. | + | **it irritates the bowel<sup>1</sup>. |
**it kills off significant amounts of the native gut flora. | **it kills off significant amounts of the native gut flora. | ||
**it significantly damages gut epithelial cells. | **it significantly damages gut epithelial cells. | ||
Line 23: | Line 23: | ||
===Population Variation=== | ===Population Variation=== | ||
+ | |||
+ | ==References== | ||
+ | # Ackermann M, Stecher B, Freed NE, Songhet P, Hardt WD, and Doebeli M. '''Self-destructive cooperation mediated by phenotypic noise'''. ''Nature'' 2008 Aug 21; 454(7207) 987-90. | ||
}} | }} |
Revision as of 17:05, 25 October 2008
People
|
Biosafety Concerns
General ConcernsSubproject ConcernsOxidative Burst
Phage Pathogen DefenseLactose IntoleranceVitamin ProductionPopulation VariationReferences
|